سعر لجنوكايين 10% بخاخ 80 مل 2022

Lignocaine (lidocaine) 10% spray (80 ml) by Arab Drug Company (ADCO) > APC (Egypt), a surface (mucosal) local anaesthetic spray.

• Prevention of pain associated with: minor non-invasive procedures in the nasal cavity, pharynx and epipharynx (e.g. rhinoscopy, laryngoscopy); supplementary pain control in obstetrics for procedures not requiring aseptic technique; insertion of instruments and catheters into the respiratory and digestive tract (endotracheal intubation, laryngoscopy, bronchoscopy, oesophagoscopy, gastroscopy); minor dental procedures.Population: Adults; children and elderly at reduced doseselectronic medicines compendium (emc)

• Local irritation at the application site; after laryngeal application, reversible sore throat, hoarseness and loss of voice; extremely rare allergic reactions (including anaphylactic shock); rare systemic CNS (nervousness, dizziness, convulsions, unconsciousness, respiratory arrest) and cardiovascular (hypotension, bradycardia, cardiac arrest) reactions from high plasma levels.International label, equivalent formulation · electronic medicines compendium (emc)

• Hypersensitivity to lidocaine, to any excipient or to amide-type local anaesthetics.International label, equivalent formulation · electronic medicines compendium (emc)

• Absorption from mucous membranes is variable and especially high from the bronchial tree, with a risk of rapidly rising plasma levels and toxicity (e.g. convulsions); use with caution on wounds or traumatised mucosa.International label, equivalent formulation · electronic medicines compendium (emc)
• Oropharyngeal use may impair swallowing and increase the risk of aspiration (especially in children); numbness of the tongue or buccal mucosa increases the risk of biting trauma.International label, equivalent formulation · electronic medicines compendium (emc)
• Use with caution in epilepsy, cardiovascular disease and heart failure, impaired cardiac conduction or bradycardia, severe renal dysfunction, impaired hepatic function, severe shock, and in elderly or debilitated patients; avoid contact with the eyes.International label, equivalent formulation · electronic medicines compendium (emc)

• Other local anaesthetics or structurally related agents (e.g. mexiletine)Additive toxic effects; use with caution.electronic medicines compendium (emc)
• Class III antiarrhythmics (e.g. amiodarone)Cardiac effects may be additive; close surveillance and ECG monitoring should be considered.electronic medicines compendium (emc)
• Drugs reducing lidocaine clearance (e.g. cimetidine, beta-blockers)May cause toxic plasma levels with repeated high doses over a long period; of no clinical importance with short-term use at recommended doses.electronic medicines compendium (emc)

• No or inadequate evidence of safety in human pregnancy, but lidocaine has been widely used for many years without apparent ill consequence and animal studies show no hazard; may be used in pregnancy if there is no safer alternative.International label, equivalent formulation · electronic medicines compendium (emc)
• Lidocaine enters breast milk in such small quantities that there is generally no risk to the child at therapeutic doses.International label, equivalent formulation · electronic medicines compendium (emc)

• Lidocaine: Stabilises the neuronal membrane by inhibiting the ionic (sodium) fluxes required for initiation and conduction of nerve impulses, producing local anaesthesia.